![]() | Up a level |
Jump to: 2014
Number of items: 1.
2014
Thomas, M., Wolf, J., Schuler, M., Goldwasser, M., Boral, A. and Shaw, A. T. (2014). Clinical activity of the ALK inhibitor LDK378 in advanced, ALK-positive NSCLC. Oncol. Res. Treat., 37. S. 89 - 91. BASEL: KARGER. ISSN 2296-5262